Who are Upstream Bio's investors?

Upstream Bio's investors include OrbiMed, Access Industries, Access Biotechnology, Bain Capital Life Sciences, Decheng Capital, HBM Healthcare Investments, HBM Partners, Samsara BioCapital and 4 more.

How much funding has Upstream Bio raised?

Upstream Bio has disclosed $50M raised across 1 of its 2 known rounds.

Where is Upstream Bio headquartered?

Upstream Bio is headquartered in Waltham, US.

Upstream Bio

NASDAQ: UPB

Waltham, US · Founded 2021 · Incorporated in Delaware · 84 employees on LinkedIn · 12 known investors

Find your way into Upstream Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the Upstream Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Upstream Bio is a biotechnology company that sponsors clinical trials to develop products under investigation. It works with clinical study staff, principal investigators, and healthcare practitioners at study sites conducting its trials.

Biotech Healthtech

Founders & leadership

Rand SutherlandChief Executive Officer

Allison Ambrose General CounselAllison Ambrose is General Counsel at Upstream Bio, a clinical trial sponsor in biotechnology. She has over 15 years of experience in corporate law and strategic advisory for life sciences companies, with expertise in securities compliance, corporate transactions, governance, and regulatory matters including FDA oversight.

Aaron Deykin Chief Medical Officer & Head of R&DHe is a physician with background in pulmonary and critical care medicine, and has held executive roles in pharmaceutical development including leading drug approvals across multiple therapeutic areas and fundraising for private and public companies.

Mike GrayChief Financial Officer and Chief Operating Officer

Adam HoughtonChief Business Officer

Stacy Price Chief Technology OfficerStacy Price is Chief Technology Officer at Upstream Bio and brings over 25 years of operations and manufacturing experience in commercial and clinical biotechnology, including work in gene and cell therapy, cGMP, facility startup, and technology transfer.

Investors · 12

OrbiMed✓ confirmed by Upstream BioNew York · $1M – $75M

How we know: OrbiMed's portfolio page · the company's own site · the S-1 prospectus · the VCSheet dataset · Not right? Tell us

Access Industries✓ confirmed by Upstream BioNew York

How we know: the company's own site · Not right? Tell us

Access Biotechnologylisted by Access BiotechnologyNew York

How we know: Access Biotechnology's portfolio page · Not right? Tell us

Bain Capital Life Scienceslisted by Bain Capital Life SciencesBoston

How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us

Decheng Capitallisted by Decheng CapitalMenlo Park

How we know: Decheng Capital's portfolio page · the S-1 prospectus · the VCSheet dataset · Not right? Tell us

HBM Healthcare Investmentslisted by HBM Healthcare InvestmentsZug

How we know: HBM Healthcare Investments's portfolio page · Not right? Tell us

HBM Partnerslisted by HBM PartnersZug · $5M – $50M

How we know: HBM Partners's portfolio page · Not right? Tell us

Samsara BioCapitallisted by Samsara BioCapitalMenlo Park

How we know: Samsara BioCapital's portfolio page · the S-1 prospectus · Not right? Tell us

TCG Crossoverlisted by TCG CrossoverPalo Alto

How we know: the S-1 prospectus · Not right? Tell us

Wellington Managementlisted by Wellington ManagementBoston · $5M – $50M

Omega FundsreportedBoston

How we know: the S-1 prospectus · Not right? Tell us

Venrock Healthcare Capital PartnersreportedNew York

How we know: the S-1 prospectus · funding news · Not right? Tell us

Valuation · disclosed

Disclosed events

$872.8Mvaluation at IPOOct 2024 · $17.00/share · 424B4

filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Frequently asked questions

What does Upstream Bio do?: Upstream Bio is a biotechnology company that sponsors clinical trials to develop products under investigation. It works with clinical study staff, principal investigators, and healthcare practitioners at study sites conducting its trials.
Who are Upstream Bio's investors?: Upstream Bio's investors include OrbiMed, Access Industries, Access Biotechnology, Bain Capital Life Sciences, Decheng Capital, HBM Healthcare Investments, HBM Partners, Samsara BioCapital and 4 more.
How much funding has Upstream Bio raised?: Upstream Bio has disclosed $50M raised across 1 of its 2 known rounds.
Where is Upstream Bio headquartered?: Upstream Bio is headquartered in Waltham, US.